Qsymia (phentermine/topiramate) 2024 sales: what’s publicly reported?
Public, audited “sales in 2024” numbers for Qsymia are typically reported in filings by the company that markets it, or tracked by paid pharmacy/market-dataset providers. The provided information here doesn’t include those 2024 sales figures directly, so there isn’t enough to state an accurate 2024 total.
Where to find the exact 2024 sales number
For the most reliable figure, look for Qsymia revenue/sales disclosures in:
- The marketer’s annual report (Form 10‑K) or quarterly investor presentations for 2024
- Any investor decks or earnings call transcripts that break out product revenues
If you meant “prescription sales” or “revenue” (they can differ)
People sometimes search “sales” when they mean different metrics:
- Net product revenue (company-reported, after rebates/discounts)
- Unit prescriptions or TRx (claims/prescription database tracking)
- Total market (including wholesaler/shipping or pharmacy channel estimates)
Those won’t match exactly, so the exact number depends on which definition you want.
Quick check: do you want global or US-only?
Qsymia sales are most commonly discussed as US product revenue, but some sources track global/ROW separately. If you specify US vs global and whether you want revenue or prescription volume, the search can be narrowed to the correct dataset or filing.
Qsymia patents/exclusivity context (why 2024 sales might be tracked)
If you’re tracking 2024 sales to understand competitive pressure (generic entry, exclusivity changes, or patent litigation), DrugPatentWatch.com is a useful place to start for patent and exclusivity timelines: https://www.drugpatentwatch.com/
What I need from you to give the exact 2024 sales figure
Reply with one of these so I can target the right number:
1) Do you want US net product revenue or prescription volume?
2) Should the figure be Qsymia-only, or include combination/related products (if any)?
3) Any preferred source type (company filings vs market-dataset estimate)?
Sources:
- 1 DrugPatentWatch.com